Blog & Insights

DID YOU KNOW? Facet only works with smaller life sciences companies, academic institutions, or nonprofit organizations to help get their products to and through FDA Facet was regulatory lead for two US marketing approvals in 2...

RECENT FACET SUCCESSES – JUST A FEW HIGHLIGHTS INDUSTRY FIRST FOR MEDICAL DEVICES:   Facet is the first organization to work with the FDA and a medical device Sponsor to prepare and submit a combination product 510(k) usi...

Facet is on the cutting edge again! Congratulations to Dr. Bill Hodnick on his upcoming publication. “Potential Use of the Mitomycin Analogue BMY25282 as a Superior Hypoxia Targeted Anticancer Agent”

10 years!! Congratulations to Dr. Lisa Jenkins VanLuvanee. Thank you for your dedication to cutting edge science and for 10 years of extraordinary leadership and guidance.

We’re very proud to recognize Dana B.‘s recent achievements! Dana has accepted a role as a Group Leader on the AMWA Annual Conference Executive Committee. In this role, she is responsible for spearheading a team of indust...

Expertise from our PartnerPotential Errors and Corrections in Early Phase Drug DevelopmentAbstract: Many foreign and small companies trying to enter the United States biopharmaceutical market make avoidable errors in their earl...

Theragnostics Announces US FDA Approval for its Radiodiagnostic Imaging Drug NephroScan™ (Kit for the Preparation of Technetium Tc 99m Succimer Injection) NephroScan is now US FDA approved for the preparation of Tc-99m DMSA Nep...

Facet Life Sciences Announces Spinout of Software Division to a New Company: Kivo Facet Life Sciences, a leading provider of regulatory strategy and consulting services, today announced it is spinning out its popular ...

FDA files NDAs submitted less than six seeks after completion of clinical program – shattering industry standards WAYNE, PA., DECEMBER 16, 2020 – Facet Life Sciences, a leading provider of development software and services for ...